Gliclazide and Halaven drug interactions - a phase IV clinical study of FDA data
Summary:
We study 32,012 people who take Gliclazide (gliclazide) and Halaven (eribulin mesylate). There is no drug interaction reported.
The study analyzes what interactions people have when they take Gliclazide and Halaven. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Gliclazide?
Gliclazide has active ingredients of gliclazide. It is often used in diabetes. eHealthMe is studying from 28,131 Gliclazide users. Check the latest studies of Gliclazide.
What is Halaven?
Halaven has active ingredients of eribulin mesylate. eHealthMe is studying from 3,881 Halaven users. Check the latest studies of Halaven.
No report is found.
Do you take Gliclazide and Halaven?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Gliclazide (28,131 reports)
- Halaven (3,881 reports)
How the study uses the data?
The study uses data from the FDA. It is based on gliclazide and eribulin mesylate (the active ingredients of Gliclazide and Halaven, respectively), and Gliclazide and Halaven (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Versed cause Ards (Acute Respiratory Distress Syndrome)? - 6 seconds ago
- Could Mirena cause Food Aversion? - 12 seconds ago
- Could Augmentin cause Erythema Multiforme? - 12 seconds ago
- Drug interactions of Miralax and Azactam - 15 seconds ago
- Drug interactions of Celebrex and Isosorbide Dinitrate - 34 seconds ago
- Could Gilenya cause Coronary Heart Disease? - 36 seconds ago
- Drug interactions of Lysine and Lumigan - 51 seconds ago
- Drug interactions of Synthroid and Blephamide - a minute ago
- Drug interactions of Topamax and Tri-Sprintec - a minute ago
- Drug interactions of Norco and Rinvoq - a minute ago